Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation

Psycho-Oncology

Volumn 17, Issue 5, 2008, Pages 480-487

  Grulke, Norbert ^a   Larbig, Wolfgang ^b   Kächele, Horst ^a   Bailer, Harald ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer; Depression; Haematopoietic stem cell transplantation; Oncology; Survival

Indexed keywords

ACUTE LEUKEMIA; ADULT; AGE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; DEPRESSION; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PROPORTIONAL HAZARDS MODEL; RADIOIMMUNOTHERAPY; RISK FACTOR; SURVIVAL RATE; TREATMENT FAILURE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; DEPRESSIVE DISORDER; FAMILY CHARACTERISTICS; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKEMIA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PROGNOSIS; PSYCHOMETRICS; RETREATMENT; RISK FACTORS; STATISTICS AS TOPIC; TREATMENT FAILURE;

EID: 44949171804     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1261     Document Type: Article

References (28)

1. Mehnert A, Lehmann C, Koch U. Prävalenz und diagnostik psychischer St_saorungen in der onkologie. Onkologe 2006;12:18-26.
2. Bottomley A. Depression in cancer patients: a literature review. Eur J Cancer Care 1998;7:181-191.
3. Spiegel D, Kato PM. Psychosocial influences on cancer incidence and progression. Harvard Rev Psychiatry 1996;4:10-26.
4. Garssen B. Psycho-oncology and cancer: linking psychosocial factors with cancer development. Ann Oncol 2002;13:171-175.
5. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-282.
6. Hoodin F, Weber S. A systematic review of psychosocial factors affecting survival after bone marrow transplantation. Psychosomatics 2003; 44:181-195.
7. Hoodin F, Uberti JP, Lynch TJ, Steele P, Ratanatharathorn V. Do negative or positive emotions differentially impact mortality after adult stem cell transplant? Bone Marrow Transplant 2006;38:255-264.
8. Prieto JM, Atala J, Blanch J et al. Role of depression as a predictor of mortality among cancer patients after stem-cell transplantation. J Clin Oncol 2005;23: 6063-6071.
9. Loberiza FR, Rizzo JD, Bredeson CN et al. Associations of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 2002; 20:2118-2126.
10. Hoodin F, Kalbfleisch KR, Thornton J, Ratanatharathorn V. Psychosocial influences on 305 adults' survival after bone marrow transplantation. Depression, smoking, and behavioral self-regulation. J Psychosom Res 2004;57:145-154.
11. Frick E, Motzke C, Fischer N, Busch R, Bumeder i. Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? Psycho-Oncology 2005;14:759-770.
12. Akaho R, Sasaki T, Mori S-I et al. Psychological factors and survival after bone marrow transplantation in patients with leukemia. Psychiatry Clin Neurosci 2003;57:91-96.
13. Andrykowski MA. Depression and survival after hematopoietic stem cell transplantation: where do we go from here? J Clin Oncol 2005; 23:5878-5880.
14. Grulke N, Bailer H, Juchems A et al. Psychosocial interventions for patients undergoing allogeneic stem cell transplantation: results of a controlled clinical study (abstract). Psycho-Oncology 2003; 112:S219.
15. Bailer H, Larbig W, Kächele H, Bunjes D, Grulke N. Wirksamkeit eines verhaltensmedizinischen Interventionsprogramms hinsichtlich Übelkeit und Erbrechen bei Patienten unter allogener Blutstammzelltransplantation. Verhaltenstherapie und Verhaltensmedizin, in press.
16. Grulke N. Psychosoziale Prädiktoren. Eine Studie zur Überlebenszeit von Patienten unter allogener hämatopoietischer Stammzelltransplantation. Ulmer Textbank: Ulm, 2007.
17. Herrmann C, Buss U, Snaith RP. HADS-D Hospital Anxiety and Depression Scale - Deutsche Version. Huber: Bern, 1995.
18. Hinz A, Schwarz R. Angst und Depression in der Allgemeinbevölkerung. Eine Normierungsstudie zur Hospital Anxiety and Depression Scale. Psychother Psychosom Med Psychol 2001;51:193-200.
19. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002; 52:69-77.
20. Gratwohl A, Hermans J, Goldman JM et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet 1998;352:1087-1092.
21. Breems DA, Van Putten WLJ, Huijgens PC et al. Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol 2005;23: 1969-1978.
22. Norusis MJ. SPSS Advanced Statistics 6.1. SPSS Inc.: Chicago, IL, 1994.
23. Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Lawrence Erlbaum Associates: Hillsdale, NJ, 1988.
24. Ringhoffer M, Wiesneth M, von Harsdorf S et al. CD34+ cell selection of peripheral blood progenitor cells using the CliniMACS device for allogeneic transplantation: clinical results in 102 patients. Br J Haematol 2004;126:527-535.
25. Foster LW, McLellan LJ, Rybicki LA, Dabney J, Welsh E, Bolwell BJ. Allogeneic BMT and patient eligibility based on psychosocial criteria: a survey of BMT professionals. Bone Marrow Transplant 2006; 27: 223-228.
26. Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 2004;52:106-111.
27. Spiegel D. Effects of psychotherapy on cancer survival. Nat Rev Cancer 2002;2:383-388.
28. Faller H. Beeinflussen psychologische Faktoren den Verlauf einer Krebserkrankung? Ergebnisse, Methoden, Mechanismen. Z Med Psychol 2004;13:99-108.